Comment: Prophylaxis for rsv hospitalization may not be cost-saving [2] (multiple letters)

Annals of Pharmacotherapy

Volumn 36, Issue 3, 2002, Pages 534-535

  Vergouwe, Yvonne ^a   Steyerberg, Ewout W ^a   Rietveld, Edwin ^b   Moll, Henriëtte A ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; HIGH RISK POPULATION; HOSPITAL COST; HOSPITALIZATION; HUMAN; INFANT; LETTER; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS;

COST-BENEFIT ANALYSIS; HOSPITALIZATION; HUMANS; INFANT, NEWBORN; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 0036197497     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.10374a     Document Type: Letter

References (0)